Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
89,127,845
-
Share change
-
-1,042,555
-
Total reported value
-
$4,977,465,562
-
Put/Call ratio
-
40%
-
Price per share
-
$55.84
-
Number of holders
-
269
-
Value change
-
-$57,613,061
-
Number of buys
-
143
-
Number of sells
-
110
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q2 2023
As of 30 Jun 2023,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,127,845 shares.
The largest 10 holders included
VANGUARD GROUP INC, BAILLIE GIFFORD & CO, FMR LLC, MORGAN STANLEY, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, ARK Investment Management LLC, BROWN CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, and SRS Investment Management, LLC.
This page lists
269
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.